General Information of Drug Transporter (DT)
DT ID DTD0262 Transporter Info
Gene Name SLC2A4
Transporter Name Glucose transporter type 4, insulin-responsive
Gene ID
6517
UniProt ID
P14672
Epigenetic Regulations of This DT (EGR)

Methylation

  Depression

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Hypermethylation of SLC2A4 in depressive disorder [ 1 ]

Location

Promoter

Epigenetic Type

Methylation Experiment Method Bisulfite sequencing

Related Molecular Changes

Down regulation of SLC2A4 Experiment Method RT-qPCR

Studied Phenotype

Depression [ ICD-11: 6A8Z]

Experimental Material

Patient tissue samples

Additional Notes

The methylation level of the GLUT4 significantly increased in depressed inpatients compared to healthy comparison subjects.

  Colon cancer

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC2A4 in colon adenocarcinoma [ 2 ]

Location

5'UTR (cg12718793)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.83E+00 Statistic Test p-value: 1.18E-03; Z-score: -2.13E+00

Methylation in Case

1.52E-01 (Median) Methylation in Control 2.79E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC2A4 in colon adenocarcinoma [ 2 ]

Location

1stExon (cg17793621)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.59E+00 Statistic Test p-value: 1.32E-06; Z-score: 2.16E+00

Methylation in Case

5.24E-01 (Median) Methylation in Control 3.29E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC2A4 in colon adenocarcinoma [ 2 ]

Location

1stExon (cg15012572)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.32E+00 Statistic Test p-value: 4.73E-03; Z-score: 1.18E+00

Methylation in Case

3.87E-02 (Median) Methylation in Control 2.94E-02 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC2A4 in colon adenocarcinoma [ 2 ]

Location

Body (cg19930802)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.04E+00 Statistic Test p-value: 7.54E-04; Z-score: -2.16E+00

Methylation in Case

8.70E-01 (Median) Methylation in Control 9.05E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Bladder cancer

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC2A4 in bladder cancer [ 3 ]

Location

TSS1500 (cg02694091)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.12E+00 Statistic Test p-value: 2.83E-02; Z-score: -1.55E+00

Methylation in Case

6.97E-02 (Median) Methylation in Control 7.79E-02 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC2A4 in bladder cancer [ 3 ]

Location

TSS200 (cg09103232)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.27E+00 Statistic Test p-value: 1.62E-02; Z-score: -1.58E+00

Methylation in Case

6.65E-02 (Median) Methylation in Control 8.43E-02 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC2A4 in bladder cancer [ 3 ]

Location

Body (cg06891043)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.31E+00 Statistic Test p-value: 1.06E-04; Z-score: -3.95E+00

Methylation in Case

4.65E-01 (Median) Methylation in Control 6.10E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC2A4 in bladder cancer [ 3 ]

Location

3'UTR (cg03670302)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.55E+00 Statistic Test p-value: 7.39E-11; Z-score: -9.71E+00

Methylation in Case

5.74E-01 (Median) Methylation in Control 8.91E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Breast cancer

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC2A4 in breast cancer [ 4 ]

Location

TSS1500 (cg02694091)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.18E+00 Statistic Test p-value: 7.72E-03; Z-score: -5.94E-01

Methylation in Case

5.95E-02 (Median) Methylation in Control 7.01E-02 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC2A4 in breast cancer [ 4 ]

Location

TSS200 (cg07287120)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.10E+00 Statistic Test p-value: 3.58E-02; Z-score: -2.67E-01

Methylation in Case

5.48E-02 (Median) Methylation in Control 6.04E-02 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC2A4 in breast cancer [ 4 ]

Location

Body (cg27067158)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.28E+00 Statistic Test p-value: 2.01E-23; Z-score: 3.87E+00

Methylation in Case

7.60E-01 (Median) Methylation in Control 5.96E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC2A4 in breast cancer [ 4 ]

Location

Body (cg21994579)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.16E+00 Statistic Test p-value: 8.82E-05; Z-score: 6.70E-01

Methylation in Case

1.10E-01 (Median) Methylation in Control 9.48E-02 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Renal cell carcinoma

           5 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC2A4 in clear cell renal cell carcinoma [ 5 ]

Location

TSS1500 (cg00064950)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.09E+00 Statistic Test p-value: 3.27E-02; Z-score: 4.49E-01

Methylation in Case

3.76E-02 (Median) Methylation in Control 3.45E-02 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC2A4 in clear cell renal cell carcinoma [ 5 ]

Location

TSS1500 (cg07723558)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.03E+00 Statistic Test p-value: 4.14E-02; Z-score: 1.79E-01

Methylation in Case

4.34E-02 (Median) Methylation in Control 4.22E-02 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC2A4 in clear cell renal cell carcinoma [ 5 ]

Location

TSS200 (cg09103232)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.41E+00 Statistic Test p-value: 4.70E-03; Z-score: -1.11E+00

Methylation in Case

2.07E-02 (Median) Methylation in Control 2.93E-02 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC2A4 in clear cell renal cell carcinoma [ 5 ]

Location

TSS200 (cg13787272)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.36E+00 Statistic Test p-value: 7.77E-03; Z-score: -9.60E-01

Methylation in Case

2.24E-02 (Median) Methylation in Control 3.06E-02 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC2A4 in clear cell renal cell carcinoma [ 5 ]

Location

Body (cg06891043)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.08E+00 Statistic Test p-value: 1.00E-06; Z-score: -2.21E+00

Methylation in Case

7.93E-01 (Median) Methylation in Control 8.57E-01 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Colorectal cancer

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC2A4 in colorectal cancer [ 6 ]

Location

TSS1500 (cg07723558)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.07E+00 Statistic Test p-value: 3.10E-02; Z-score: 5.21E-01

Methylation in Case

1.23E-01 (Median) Methylation in Control 1.15E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC2A4 in colorectal cancer [ 6 ]

Location

TSS200 (cg25362068)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.20E+00 Statistic Test p-value: 3.05E-02; Z-score: -3.61E-01

Methylation in Case

2.26E-02 (Median) Methylation in Control 2.70E-02 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC2A4 in colorectal cancer [ 6 ]

Location

Body (cg21994579)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.21E+00 Statistic Test p-value: 9.88E-06; Z-score: 9.32E-01

Methylation in Case

1.78E-01 (Median) Methylation in Control 1.48E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Pancretic ductal adenocarcinoma

           3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC2A4 in pancretic ductal adenocarcinoma [ 7 ]

Location

TSS1500 (cg15971010)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.23E+00 Statistic Test p-value: 5.90E-07; Z-score: 1.39E+00

Methylation in Case

3.82E-01 (Median) Methylation in Control 3.11E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC2A4 in pancretic ductal adenocarcinoma [ 7 ]

Location

TSS200 (cg06463759)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.36E+00 Statistic Test p-value: 1.53E-02; Z-score: -8.26E-01

Methylation in Case

6.70E-02 (Median) Methylation in Control 9.14E-02 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC2A4 in pancretic ductal adenocarcinoma [ 7 ]

Location

Body (cg22574986)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.17E+00 Statistic Test p-value: 1.48E-03; Z-score: 5.74E-01

Methylation in Case

8.68E-02 (Median) Methylation in Control 7.40E-02 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Prostate cancer

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC2A4 in prostate cancer [ 8 ]

Location

TSS1500 (cg07903677)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.51E+00 Statistic Test p-value: 2.72E-03; Z-score: 6.45E+00

Methylation in Case

6.99E-01 (Median) Methylation in Control 4.64E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC2A4 in prostate cancer [ 8 ]

Location

Body (cg15266604)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.04E+00 Statistic Test p-value: 7.79E-04; Z-score: 4.13E+00

Methylation in Case

9.48E-01 (Median) Methylation in Control 9.08E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Systemic lupus erythematosus

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC2A4 in systemic lupus erythematosus [ 9 ]

Location

TSS1500 (cg00064950)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.03E+00 Statistic Test p-value: 1.47E-02; Z-score: -1.36E-01

Methylation in Case

9.53E-02 (Median) Methylation in Control 9.76E-02 (Median)

Studied Phenotype

Systemic lupus erythematosus [ ICD-11: 4A40.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC2A4 in systemic lupus erythematosus [ 9 ]

Location

TSS1500 (cg02694091)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 2.62E-02; Z-score: -1.19E-01

Methylation in Case

7.69E-02 (Median) Methylation in Control 7.87E-02 (Median)

Studied Phenotype

Systemic lupus erythematosus [ ICD-11: 4A40.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC2A4 in systemic lupus erythematosus [ 9 ]

Location

TSS200 (cg13787272)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 1.99E-04; Z-score: -1.15E-01

Methylation in Case

8.43E-02 (Median) Methylation in Control 8.61E-02 (Median)

Studied Phenotype

Systemic lupus erythematosus [ ICD-11: 4A40.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC2A4 in systemic lupus erythematosus [ 9 ]

Location

Body (cg06891043)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 4.37E-02; Z-score: -2.79E-01

Methylation in Case

7.05E-01 (Median) Methylation in Control 7.23E-01 (Median)

Studied Phenotype

Systemic lupus erythematosus [ ICD-11: 4A40.0]

Experimental Material

Patient tissue samples

  Panic disorder

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC2A4 in panic disorder [ 10 ]

Location

TSS200 (cg07287120)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 9.93E-01 Statistic Test p-value: 3.22E-02; Z-score: 1.48E-01

Methylation in Case

-4.98E+00 (Median) Methylation in Control -5.01E+00 (Median)

Studied Phenotype

Panic disorder [ ICD-11: 6B01]

Experimental Material

Patient tissue samples

  Papillary thyroid cancer

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC2A4 in papillary thyroid cancer [ 11 ]

Location

TSS200 (cg26480745)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.11E+00 Statistic Test p-value: 2.47E-03; Z-score: -5.32E-01

Methylation in Case

1.45E-01 (Median) Methylation in Control 1.60E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Atypical teratoid rhabdoid tumor

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC2A4 in atypical teratoid rhabdoid tumor [ 12 ]

Location

Body (cg06891043)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.10E+00 Statistic Test p-value: 3.08E-03; Z-score: 7.14E-01

Methylation in Case

7.98E-01 (Median) Methylation in Control 7.27E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC2A4 in atypical teratoid rhabdoid tumor [ 12 ]

Location

3'UTR (cg03670302)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.26E+00 Statistic Test p-value: 1.31E-14; Z-score: -2.60E+00

Methylation in Case

6.85E-01 (Median) Methylation in Control 8.60E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Hepatocellular carcinoma

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC2A4 in hepatocellular carcinoma [ 13 ]

Location

Body (cg03924551)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.43E+00 Statistic Test p-value: 1.47E-15; Z-score: -4.73E+00

Methylation in Case

5.42E-01 (Median) Methylation in Control 7.77E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC2A4 in hepatocellular carcinoma [ 13 ]

Location

Body (cg13532410)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.47E+00 Statistic Test p-value: 1.13E-12; Z-score: -1.76E+00

Methylation in Case

3.34E-01 (Median) Methylation in Control 4.91E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC2A4 in hepatocellular carcinoma [ 13 ]

Location

Body (cg27067158)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 6.68E-03; Z-score: -7.42E-01

Methylation in Case

8.27E-01 (Median) Methylation in Control 8.38E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC2A4 in hepatocellular carcinoma [ 13 ]

Location

3'UTR (cg03670302)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.04E+00 Statistic Test p-value: 1.22E-06; Z-score: -1.79E+00

Methylation in Case

8.91E-01 (Median) Methylation in Control 9.28E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  HIV infection

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC2A4 in HIV infection [ 14 ]

Location

Body (cg21994579)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.46E+00 Statistic Test p-value: 6.25E-05; Z-score: 1.76E+00

Methylation in Case

1.27E-01 (Median) Methylation in Control 8.71E-02 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC2A4 in HIV infection [ 14 ]

Location

3'UTR (cg03670302)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.05E+00 Statistic Test p-value: 3.09E-13; Z-score: 2.13E+00

Methylation in Case

9.44E-01 (Median) Methylation in Control 9.00E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Lung adenocarcinoma

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC2A4 in lung adenocarcinoma [ 15 ]

Location

Body (cg06891043)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.06E+00 Statistic Test p-value: 2.16E-02; Z-score: -1.23E+00

Methylation in Case

7.14E-01 (Median) Methylation in Control 7.54E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC2A4 in lung adenocarcinoma [ 15 ]

Location

3'UTR (cg03670302)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.03E+00 Statistic Test p-value: 8.98E-03; Z-score: -1.79E+00

Methylation in Case

8.86E-01 (Median) Methylation in Control 9.09E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Lymphoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypermethylation of SLC2A4 in lymphoma than that in healthy individual

Studied Phenotype

Lymphoma [ICD-11:2B30]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 1.30E-11; Fold-change: 0.496755918; Z-score: 25.16026682
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

Histone acetylation

  Non-small cell lung cancer

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Hypoacetylation of SLC2A4 in non-small cell lung cancer (compare with Vorinostat-treatment counterpart cells) [ 16 ]

Location

Promoter

Epigenetic Type

Histone acetylation Experiment Method Chromatin immunoprecipitation

Related Molecular Changes

Down regulation of SLC2A4 Experiment Method RT-qPCR

Studied Phenotype

Non-small cell lung cancer [ ICD-11: 2C25.4]

Experimental Material

Multiple cell lines of human

Additional Notes

SLC2A4 expression can be induced or increased following inhibition of histone deacetylases in non-small cell lung cancer cell lines.

  Type 1 diabetes

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Hypoacetylation of SLC2A4 in type 1 diabete (compare with counterpart normal rat cells) [ 17 ]

Location

Promoter

Epigenetic Type

Histone acetylation Experiment Method Chromatin immunoprecipitation

Related Molecular Changes

Down regulation of SLC2A4 Experiment Method Western Blot

Studied Phenotype

Type 1 diabetes [ ICD-11: 5A10]

Experimental Material

Model organism in vivo (mouse)

Additional Notes

The Type 1 diabetes reduced the H3Kac which would decrease the binding of transcription factors.

  Type 2 diabetes

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Hypoacetylation of SLC2A4 in type 2 diabete (compare with counterpart normal rat cells) [ 17 ]

Location

Promoter

Epigenetic Type

Histone acetylation Experiment Method Chromatin immunoprecipitation

Related Molecular Changes

Down regulation of SLC2A4 Experiment Method Western Blot

Studied Phenotype

Type 2 diabetes [ ICD-11: 5A11]

Experimental Material

Model organism in vivo (mouse)

Additional Notes

The Type 2 diabetes reduced the H3Kac which would decrease the binding of transcription factors.

Histone trimethylation

  Type 1 diabetes

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Higher level of histone trimethylation of SLC2A4 in type 1 diabete (compare with counterpart normal rat cells) [ 17 ]

Location

Promoter

Epigenetic Type

Histone trimethylation Experiment Method Chromatin immunoprecipitation

Related Molecular Changes

Down regulation of SLC2A4 Experiment Method Western Blot

Studied Phenotype

Type 1 diabetes [ ICD-11: 5A10]

Experimental Material

Model organism in vivo (mouse)

Additional Notes

The Type 1 diabetes reduced the H3Kac and increased the H3K9me3 content, and insulin treatment reversed only the H3K9me3 modification.

  Type 2 diabetes

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Lower level of histone trimethylation of SLC2A4 in type 2 diabete (compare with counterpart normal rat cells) [ 17 ]

Location

Promoter

Epigenetic Type

Histone trimethylation Experiment Method Chromatin immunoprecipitation

Related Molecular Changes

Down regulation of SLC2A4 Experiment Method Western Blot

Studied Phenotype

Type 2 diabetes [ ICD-11: 5A11]

Experimental Material

Model organism in vivo (mouse)

Additional Notes

The Type 2 diabetes reduced the H3Kac and increased the H3K9me3 content, and insulin treatment reversed only the H3K9me3 modification.

microRNA

  Unclear Phenotype

         28 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

miR-1286 directly targets SLC2A4 [ 18 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-1286 miRNA Mature ID miR-1286

miRNA Sequence

UGCAGGACCAAGAUGAGCCCU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 2

miR-1321 directly targets SLC2A4 [ 18 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-1321 miRNA Mature ID miR-1321

miRNA Sequence

CAGGGAGGUGAAUGUGAU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 3

miR-3121 directly targets SLC2A4 [ 19 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-3121 miRNA Mature ID miR-3121-5p

miRNA Sequence

UCCUUUGCCUAUUCUAUUUAAG

miRNA Target Type

Direct

Experimental Material

Left ventricular cardiac tissues of human

  Epigenetic Phenomenon 4

miR-335 directly targets SLC2A4 [ 20 ]

Epigenetic Type

microRNA Experiment Method Microarray

miRNA Stemloop ID

miR-335 miRNA Mature ID miR-335-5p

miRNA Sequence

UCAAGAGCAAUAACGAAAAAUGU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 5

miR-4436a directly targets SLC2A4 [ 18 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-4436a miRNA Mature ID miR-4436a

miRNA Sequence

GCAGGACAGGCAGAAGUGGAU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 6

miR-4510 directly targets SLC2A4 [ 18 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-4510 miRNA Mature ID miR-4510

miRNA Sequence

UGAGGGAGUAGGAUGUAUGGUU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 7

miR-4709 directly targets SLC2A4 [ 18 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-4709 miRNA Mature ID miR-4709-3p

miRNA Sequence

UUGAAGAGGAGGUGCUCUGUAGC

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 8

miR-4739 directly targets SLC2A4 [ 18 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-4739 miRNA Mature ID miR-4739

miRNA Sequence

AAGGGAGGAGGAGCGGAGGGGCCCU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 9

miR-4756 directly targets SLC2A4 [ 18 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-4756 miRNA Mature ID miR-4756-5p

miRNA Sequence

CAGGGAGGCGCUCACUCUCUGCU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 10

miR-5000 directly targets SLC2A4 [ 18 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-5000 miRNA Mature ID miR-5000-3p

miRNA Sequence

UCAGGACACUUCUGAACUUGGA

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 11

miR-548ac directly targets SLC2A4 [ 19 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-548ac miRNA Mature ID miR-548ac

miRNA Sequence

CAAAAACCGGCAAUUACUUUUG

miRNA Target Type

Direct

Experimental Material

Left ventricular cardiac tissues of human

  Epigenetic Phenomenon 12

miR-548as directly targets SLC2A4 [ 19 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-548as miRNA Mature ID miR-548as-3p

miRNA Sequence

UAAAACCCACAAUUAUGUUUGU

miRNA Target Type

Direct

Experimental Material

Left ventricular cardiac tissues of human

  Epigenetic Phenomenon 13

miR-548bb directly targets SLC2A4 [ 19 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-548bb miRNA Mature ID miR-548bb-3p

miRNA Sequence

CAAAAACCAUAGUUACUUUUGC

miRNA Target Type

Direct

Experimental Material

Left ventricular cardiac tissues of human

  Epigenetic Phenomenon 14

miR-548d directly targets SLC2A4 [ 19 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-548d miRNA Mature ID miR-548d-3p

miRNA Sequence

CAAAAACCACAGUUUCUUUUGC

miRNA Target Type

Direct

Experimental Material

Left ventricular cardiac tissues of human

  Epigenetic Phenomenon 15

miR-548h directly targets SLC2A4 [ 19 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-548h miRNA Mature ID miR-548h-3p

miRNA Sequence

CAAAAACCGCAAUUACUUUUGCA

miRNA Target Type

Direct

Experimental Material

Left ventricular cardiac tissues of human

  Epigenetic Phenomenon 16

miR-548z directly targets SLC2A4 [ 19 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-548z miRNA Mature ID miR-548z

miRNA Sequence

CAAAAACCGCAAUUACUUUUGCA

miRNA Target Type

Direct

Experimental Material

Left ventricular cardiac tissues of human

  Epigenetic Phenomenon 17

miR-6077 directly targets SLC2A4 [ 18 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-6077 miRNA Mature ID miR-6077

miRNA Sequence

GGGAAGAGCUGUACGGCCUUC

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 18

miR-6127 directly targets SLC2A4 [ 18 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-6127 miRNA Mature ID miR-6127

miRNA Sequence

UGAGGGAGUGGGUGGGAGG

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 19

miR-6129 directly targets SLC2A4 [ 18 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-6129 miRNA Mature ID miR-6129

miRNA Sequence

UGAGGGAGUUGGGUGUAUA

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 20

miR-6130 directly targets SLC2A4 [ 18 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-6130 miRNA Mature ID miR-6130

miRNA Sequence

UGAGGGAGUGGAUUGUAUG

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 21

miR-6133 directly targets SLC2A4 [ 18 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-6133 miRNA Mature ID miR-6133

miRNA Sequence

UGAGGGAGGAGGUUGGGUA

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 22

miR-6771 directly targets SLC2A4 [ 19 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-6771 miRNA Mature ID miR-6771-3p

miRNA Sequence

CAAACCCCUGUCUACCCGCAG

miRNA Target Type

Direct

Experimental Material

Left ventricular cardiac tissues of human

  Epigenetic Phenomenon 23

miR-6782 directly targets SLC2A4 [ 18 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-6782 miRNA Mature ID miR-6782-5p

miRNA Sequence

UAGGGGUGGGGGAAUUCAGGGGUGU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 24

miR-6873 directly targets SLC2A4 [ 18 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-6873 miRNA Mature ID miR-6873-5p

miRNA Sequence

CAGAGGGAAUACAGAGGGCAAU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 25

miR-6880 directly targets SLC2A4 [ 18 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-6880 miRNA Mature ID miR-6880-5p

miRNA Sequence

UGGUGGAGGAAGAGGGCAGCUC

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 26

miR-7106 directly targets SLC2A4 [ 18 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-7106 miRNA Mature ID miR-7106-5p

miRNA Sequence

UGGGAGGAGGGGAUCUUGGG

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 27

miR-766 directly targets SLC2A4 [ 18 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-766 miRNA Mature ID miR-766-5p

miRNA Sequence

AGGAGGAAUUGGUGCUGGUCUU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 28

miR-92a-1 directly targets SLC2A4 [ 21 ]

Epigenetic Type

microRNA Experiment Method CLASH

miRNA Stemloop ID

miR-92a-1 miRNA Mature ID miR-92a-1-5p

miRNA Sequence

AGGUUGGGAUCGGUUGCAAUGCU

miRNA Target Type

Direct

Experimental Material

Human embryonic kidney 293 cells (HEK293)
References
1 Altered DNA methylation of glucose transporter 1 and glucose transporter 4 in patients with major depressive disorder. J Psychiatr Res. 2016 May;76:66-73.
2 Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips. Epigenetics. 2013 Sep;8(9):921-34.
3 DNA Methylation Dynamics in Urological Tumors.
4 Genome-wide Scan for Methylation Profiles in Breast Cancer
5 A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma. Nat Commun. 2015 Oct 30;6:8699.
6 Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology. 2014 Aug;147(2):418-29.e8.
7 Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int J Cancer. 2014 Sep 1;135(5):1110-8.
8 Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array. BMC Genomics. 2014 Jan 22;15:51.
9 Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations. PLoS Genet. 2013;9(8):e1003678.
10 DNA Methylation signatures in panic disorder. Transl Psychiatry. 2017 Dec 18;7(12):1287.
11 Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors. J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099.
12 Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes. Cancer Cell. 2016 Mar 14;29(3):379-393.
13 Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics. 2013 Jan;8(1):34-43.
14 HIV-1 Infection Accelerates Age According to the Epigenetic Clock. J Infect Dis. 2015 Nov 15;212(10):1563-73.
15 DNA methylation analysis of lung adenocarcinoma and adjacent non-tumor tissues
16 Epigenetic regulation of glucose transporters in non-small cell lung cancer. Mol Ther Oncolytics. 2019 Feb 5;12:235-245.
17 Diabetes induces tri-methylation at lysine 9 of histone 3 at Slc2a4 gene in skeletal muscle: A new target to improve glycemic control. Mol Cell Endocrinol. 2019 Feb 5;481:26-34.
18 In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms. MBio. 2013 Apr 16;4(2):e000193.
19 Elucidation of transcriptome-wide microRNA binding sites in human cardiac tissues by Ago2 HITS-CLIP. Nucleic Acids Res. 2016 Sep 6;44(15):7120-31.
20 Endogenous human microRNAs that suppress breast cancer metastasis. Nature. 2008 Jan 10;451(7175):147-52.
21 Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell. 2013 Apr 25;153(3):654-65.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.